Literature DB >> 32361040

Early-life ketamine exposure attenuates the preference for ethanol in adolescent Sprague-Dawley rats.

Daniela Franco1, Jennifer Zamudio1, Kennedy M Blevins1, Eric A Núñez-Larios1, Ulises M Ricoy2, Sergio D Iñiguez3, Arturo R Zavala4.   

Abstract

Ketamine, a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, produces quick and effective antidepressant results in depressed juvenile and adult individuals. The long-term consequences of using ketamine in juvenile populations are not well known, particularly as it affects vulnerability to drugs of abuse later in life, given that ketamine is also a drug of abuse. Thus, the current study examined whether early-life ketamine administration produces long-term changes in the sensitivity to the rewarding effects of ethanol, as measured using the conditioned place preference (CPP) paradigm. On postnatal day (PD) 21, juvenile male and female rats were pretreated with ketamine (0.0 or 20 mg/kg) for 10 consecutive days (i.e., PD 21-30) and then evaluated for ethanol-induced CPP (0.0, 0.125, 0.5, or 2.0 g/kg) from PD 32-39. Results revealed that early-life ketamine administration attenuated the rewarding properties of ethanol in male rats, as ketamine pretreated rats failed to exhibit ethanol-induced CPP at any dose compared to saline pretreated rats, which showed an increased preference towards the ethanol-paired compartment in a dose-dependent manner. In females, ethanol-induced CPP was generally less robust compared to males, but ketamine pretreatment resulted in a rightward shift in the dose-response curve, given that ketamine pretreated rats needed a higher dose of ethanol compared to saline pretreated rats to exhibit ethanol-induced CPP. When considered together, the findings suggest that early use of ketamine does not appear to enhance the vulnerability to ethanol later in life, but in contrast, it may attenuate the rewarding effects of ethanol.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Adolescence; Alcohol; Anhedonia; CPP; Reward

Mesh:

Substances:

Year:  2020        PMID: 32361040      PMCID: PMC7521832          DOI: 10.1016/j.bbr.2020.112626

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  51 in total

1.  Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.

Authors:  Fangqiong Li; Qin Fang; Yu Liu; Mei Zhao; Dapeng Li; Jishi Wang; Lin Lu
Journal:  Eur J Pharmacol       Date:  2008-05-06       Impact factor: 4.432

2.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

3.  Place conditioning: age-related changes in the rewarding and aversive effects of alcohol.

Authors:  R M Philpot; K A Badanich; C L Kirstein
Journal:  Alcohol Clin Exp Res       Date:  2003-04       Impact factor: 3.455

4.  Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development.

Authors:  Oscar V Torres; Hugo A Tejeda; Luis A Natividad; Laura E O'Dell
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

5.  Postnatal development of glutamate receptor-mediated responses in the neostriatum.

Authors:  C S Colwell; C Cepeda; C Crawford; M S Levine
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

6.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

7.  Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life.

Authors:  Francisco J Flores-Ramirez; Israel Garcia-Carachure; David O Sanchez; Celene Gonzalez; Samuel A Castillo; Miguel A Arenivar; Anapaula Themann; Omar Lira; Minerva Rodriguez; Joshua Preciado-Piña; Sergio D Iñiguez
Journal:  J Psychopharmacol       Date:  2018-10-18       Impact factor: 4.153

8.  Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.

Authors:  Xian-Cang Ma; Yong-Hui Dang; Min Jia; Rui Ma; Fen Wang; Jin Wu; Cheng-Ge Gao; Kenji Hashimoto
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

9.  NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Polymnia Georgiou; Jonathan Fischell; Greg I Elmer; Manickavasagom Alkondon; Peixiong Yuan; Heather J Pribut; Nagendra S Singh; Katina S S Dossou; Yuhong Fang; Xi-Ping Huang; Cheryl L Mayo; Irving W Wainer; Edson X Albuquerque; Scott M Thompson; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Nature       Date:  2016-05-04       Impact factor: 49.962

10.  Ketamine Differentially Attenuates Alcohol Intake in Male Versus Female Alcohol Preferring (P) Rats.

Authors:  Amir H Rezvani; Edward D Levin; Marty Cauley; Bruk Getachew; Yousef Tizabi
Journal:  J Drug Alcohol Res       Date:  2017-07-28
View more
  2 in total

1.  Repeated ketamine anesthesia during neurodevelopment upregulates hippocampal activity and enhances drug reward in male mice.

Authors:  Jianchen Cui; Xianshu Ju; Yulim Lee; Boohwi Hong; Hyojin Kang; Kihoon Han; Won-Ho Shin; Jiho Park; Min Joung Lee; Yoon Hee Kim; Youngkwon Ko; Jun Young Heo; Woosuk Chung
Journal:  Commun Biol       Date:  2022-07-15

2.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.